Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis. (29th March 2022)
- Record Type:
- Journal Article
- Title:
- Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis. (29th March 2022)
- Main Title:
- Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis
- Authors:
- Liu, Menglu
Mei, Kaibo
Tan, Ziqi
Huang, Shan
Liu, Fuwei
Deng, Chao
Ma, Jianyong
Yu, Peng
Liu, Xiao - Other Names:
- Marasco Giovanni Academic Editor.
- Abstract:
- Abstract : Background and Aim . The relationship between liver fibrosis scores and clinical outcomes in patients with COVID-19 is not compressively assessed. Methods . We identified relevant cohort studies that assessed the relationship between liver fibrosis scores (e.g., FIB-4, NAFLD fibrosis score (NFS), and aspartate aminotransferase to platelet ratio index (APRI)) and associated prognosis outcomes by searching the PubMed, EMBASE, and medRxiv databases. The potential dose-response effect was performed using a stage robust error meta-regression. Results . Sixteen studies with 8, 736 hospitalized patients with COVID-19 were included. One-point score in FIB-4 increase was significantly associated with increased mechanical ventilation (RR: 2.23, 95% CI: 1.37–3.65, P = 0.001 ), severe COVID-19 (RR: 1.82, 95% CI: 1.53–2.16, P < 0.001 ), and death (RR: 1.47, 95% CI: 1.31–1.65, P < 0.001 ), rather than hospitalization (RR: 1.35, 95% CI: 0.72–2.56, P = 0.35 ). Furthermore, there is a significant positive linear relationship between FIB-4 and severe COVID-19 (P nonlinearity = 0.12 ) and mortality (P nonlinearity = 0.18 ). Regarding other liver scores, one unit elevation in APRI increased the risk of death by 178% (RR: 2.78, 95% CI: 1.10–6.99, P = 0.03 ). Higher NFS (≥−1.5) and Forns index were associated with increased risk of severe COVID-19 and COVID-19-associated death. Conclusion . Our dose-response meta-analysis suggests high liver fibrosis scores are associated with worseAbstract : Background and Aim . The relationship between liver fibrosis scores and clinical outcomes in patients with COVID-19 is not compressively assessed. Methods . We identified relevant cohort studies that assessed the relationship between liver fibrosis scores (e.g., FIB-4, NAFLD fibrosis score (NFS), and aspartate aminotransferase to platelet ratio index (APRI)) and associated prognosis outcomes by searching the PubMed, EMBASE, and medRxiv databases. The potential dose-response effect was performed using a stage robust error meta-regression. Results . Sixteen studies with 8, 736 hospitalized patients with COVID-19 were included. One-point score in FIB-4 increase was significantly associated with increased mechanical ventilation (RR: 2.23, 95% CI: 1.37–3.65, P = 0.001 ), severe COVID-19 (RR: 1.82, 95% CI: 1.53–2.16, P < 0.001 ), and death (RR: 1.47, 95% CI: 1.31–1.65, P < 0.001 ), rather than hospitalization (RR: 1.35, 95% CI: 0.72–2.56, P = 0.35 ). Furthermore, there is a significant positive linear relationship between FIB-4 and severe COVID-19 (P nonlinearity = 0.12 ) and mortality (P nonlinearity = 0.18 ). Regarding other liver scores, one unit elevation in APRI increased the risk of death by 178% (RR: 2.78, 95% CI: 1.10–6.99, P = 0.03 ). Higher NFS (≥−1.5) and Forns index were associated with increased risk of severe COVID-19 and COVID-19-associated death. Conclusion . Our dose-response meta-analysis suggests high liver fibrosis scores are associated with worse prognosis in patients with COVID-19. For patients with COVID-19 at admission, especially for those with coexisting chronic liver diseases, assessment of liver fibrosis scores might be useful for identifying high risk of developing severe COVID-19 cases and worse outcomes. … (more)
- Is Part Of:
- Canadian journal of gastroenterology & hepatology. Volume 2022(2022)
- Journal:
- Canadian journal of gastroenterology & hepatology
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03-29
- Subjects:
- Digestive organs -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Digestive organs -- Diseases
Gastroenterology
Canada
Digestive System Diseases -- Periodicals
Gastroenterology -- Periodicals
Periodicals
Electronic journals
Fulltext
Internet Resources
Periodicals
616.3 - Journal URLs:
- https://www.hindawi.com/journals/cjgh/ ↗
http://bibpurl.oclc.org/web/74585 ↗
https://www.ncbi.nlm.nih.gov/pmc/journals/2438/ ↗
http://search.proquest.com/publication/2032234 ↗
http://resolver.library.ualberta.ca/resolver?ctx_enc=info%3Aofi%2Fenc%3AUTF-8&ctx_ver=Z39.88-2004&rfr_id=info%3Asid%2Fualberta.ca%3Aopac&rft.genre=journal&rft.object_id=2670000000550207&rft.issn=2291-2789&rft.eissn=2291-2797&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&url_ctx_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Actx&url_ver=Z39.88-2004 ↗
http://resolver.lrc.macewan.ca/macewan?url%5Fver=Z39.88-2004&ctx%5Fver=Z39.88-2004&ctx%5Fenc=info:ofi/enc:UTF-8&rfr%5Fid=info:sid/sfxit.com:opac%5F856&url%5Fctx%5Ffmt=info:ofi/fmt:kev:mtx:ctx&sfx.ignore%5Fdate%5Fthreshold=1&rft.object%5Fid=2670000000550207&svc%5Fval%5Ffmt=info:ofi/fmt:kev:mtx:sch%5Fsvc& ↗ - DOI:
- 10.1155/2022/7235860 ↗
- Languages:
- English
- ISSNs:
- 2291-2789
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21440.xml